A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies

Conditions:   Lymphoma, Non-Hodgkin;   Lymphoma, Large B-Cell, Diffuse;   Lymphoma, Mantle-Cell;   Lymphoma, Follicular;   Lymphoma, B-Cell Intervention:   Drug: ALETA-001 Sponsors:   Cancer Research UK;   Aleta BioTherapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials